The FDA approves an expedited enrollment plan for a 5-patient pivotal study testing InVivo Therapeutics' neuro-spinal scaffold devices in the treatment of severe spinal cord injuries.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AkjEt7
Cap comentari:
Publica un comentari a l'entrada